Navigating the Transition to Next-Generation Propellants in Inhalation Drug Development

The pressurized metered dose inhaler (pMDI) industry is undergoing one of the most significant transformations in decades with the transition to next-generation propellants (NGPs). Join Kindeva to explore how exceptional facilities, decades of pMDI expertise, and strategic guidance can help innovators navigate this change with confidence.

Register Free: https://www.pharmtech.com/pt_w/propellants

Event Overview:

The global move toward next-generation propellants (NGPs) represents a critical moment for pulmonary drug developers, with regulatory pressure and sustainability commitments driving rapid change. In this webinar, Kindeva experts will outline how the company’s deep legacy in inhalation drug delivery and its investment in state-of-the-art facilities uniquely position it to support customers through this transition. Attendees will gain insights into the challenges and opportunities of adopting NGPs, as well as practical guidance on how to leverage Kindeva’s capabilities, from formulation and device development to clinical supply and commercial-scale manufacturing. By spotlighting Kindeva’s new facility and capabilities, the session will demonstrate how the company partners with customers to ensure future-ready, compliant, and patient-centric pulmonary therapies.

Key Learning Objectives:

• Understand the drivers behind the industry’s transition to NGPs, including the regulatory and societal landscape shaping the shift.
• Learn how Kindeva’s exceptional by design CDMO capabilities and clinical-to-commercial-scale NGP manufacturing can enable a smooth and accelerated transition.
• Explore Kindeva’s new pMDI headquarters and discover how our cutting-edge technologies and comprehensive CDMO solutions provide customers with scalable, sustainable pMDI product development and manufacturing.

Who Should Attend:

• Directors of quality assurance/quality
• Heads of quality control
• Vice presidents of quality
• Senior vice presidents of research, lead researchers, heads of research, vice presidents of research, senior research directors
• Directors/heads of manufacturing, heads of operations, presidents, chief executive officers, managing directors
• Vice presidents of global sourcing, chief procurement officers, directors of procurement
• Directors of business development, vice presidents of commercial sales, regional vice presidents of sales
• Heads of laboratory, biomedical engineers, biochemists, chief scientific officers, chief technology officers

Speaker:

Craig Sommerville
Senior Vice President, MDI
Kindeva

Craig Sommerville, senior vice president of Kindeva’s metered-dose inhaler (MDI) business unit, is responsible for shaping and executing the MDI platform’s global strategy, focusing on leading the industrialization of the green propellant transition. With over 25 years of experience in increasingly senior roles across site leadership, supply chain strategy, operations, logistics, procurement, and technical functions, Sommerville brings a proven track record of transforming challenges into opportunities.

Register Free: https://www.pharmtech.com/pt_w/propellants